{
"info": {
"nct_id": "NCT02217020",
"official_title": "A Phase II Study of Neoadjuvant FOLFOXIRI Chemotherapy Alone in Treating Patients With Locally Advanced Rectal Cancer",
"inclusion_criteria": "Healthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 70 Years",
"exclusion_criteria": "* Hypersensitivity to fluorouracil, oxaliplatin or irinotecan.\n* No More than 4 weeks since prior participation in any investigational drug study\n* More than 4 weeks since prior participation in any investigational drug study\n* Clear indication of involvement of the pelvic side walls by imaging\n* With distant metastasis\n* History of invasive rectal malignancy, regardless of disease-free interval\n* Fertile patients must use effective contraception\n* Uncontrolled hypertension\n* Cardiovascular disease that would preclude study treatment or follow-up\n* Lack of upper gastrointestinal tract integrity or malabsorption syndrome,active upper gastrointestinal tract bleeding\n* Synchronous colon cancer\n* Pregnant or nursing, Fertile patients do not use effective contraception\n* Other malignancy within the past 5 years except effectively treated squamous cell or basal cell skin cancer, melanoma in situ, carcinoma in situ of the cervix, or carcinoma in situ of the colon or rectum\n* No psychiatric or addictive disorders, or other conditions that, in the opinion of the investigator, would preclude study participation\n* patients refused to signed informed consent.",
"miscellaneous_criteria": "Inclusion Criteria\n\n* Diagnosis of adenocarcinoma of the rectum\n* Age: 18-70 years old\n* Signed informed consent; able to comply with study and/or follow- up procedures\n* Stage of the primary tumor may be determined by ultrasound or MRI\n* Stage II (T3-4, N0 [N0 is defined as all imaged lymph nodes < 1.0 cm]) OR stage III (T1-4, N1-2 [with the definition of a clinically positive lymph node being any node ≥ 1.0 cm]\n* Tumor palpable by digital rectal exam OR accessible by proctoscope or sigmoidoscope\n* Distal border of the tumor must be located < 12 cm from the anal verge\n* Tumor amenable to curative resection\n* Adequate bone marrow, hepatic and renal function as assessed by the following laboratory requirements conducted within 7 days of starting study treatment:\n* Leukocytes ≥ 3.0 x109/ L, absolute neutrophil count (ANC) ≥ 1.5 x109/ L, platelet count ≥ 100 x109/ L, hemoglobin (Hb) ≥ 9g/ dL.\n* Total bilirubin ≤1.5 x the upper limit of normal (ULN).\n* Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤ 5 x ULN.\n* Alkaline phosphatase limit ≤ 5x ULN.\n* Amylase and lipase ≤ 1.5 x the ULN.\n* Serum creatinine ≤ 1.5 x the ULN.\n* Calculated creatinine clearance or 24 hour creatinine clearance ≥ 50 mL/ min.\n* No renal disease that would preclude study treatment or follow-up\n* ECOG status: 0~1"
},
"inclusion_lines": [
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
},
{
"line": "Must have maximum age of 70 Years",
"criterions": [
{
"exact_snippets": "maximum age of 70 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 70,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Hypersensitivity to fluorouracil, oxaliplatin or irinotecan.",
"criterions": [
{
"exact_snippets": "Hypersensitivity to fluorouracil",
"criterion": "hypersensitivity to fluorouracil",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Hypersensitivity to ... oxaliplatin",
"criterion": "hypersensitivity to oxaliplatin",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Hypersensitivity to ... irinotecan",
"criterion": "hypersensitivity to irinotecan",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* No More than 4 weeks since prior participation in any investigational drug study",
"criterions": [
{
"exact_snippets": "No More than 4 weeks since prior participation in any investigational drug study",
"criterion": "time since prior investigational drug study participation",
"requirements": [
{
"requirement_type": "time elapsed",
"expected_value": {
"operator": "<=",
"value": 4,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "* More than 4 weeks since prior participation in any investigational drug study",
"criterions": [
{
"exact_snippets": "More than 4 weeks since prior participation in any investigational drug study",
"criterion": "participation in investigational drug study",
"requirements": [
{
"requirement_type": "time since last participation",
"expected_value": {
"operator": ">",
"value": 4,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "* Clear indication of involvement of the pelvic side walls by imaging",
"criterions": [
{
"exact_snippets": "involvement of the pelvic side walls by imaging",
"criterion": "pelvic side wall involvement",
"requirements": [
{
"requirement_type": "detection method",
"expected_value": "imaging"
}
]
}
]
},
{
"line": "* With distant metastasis",
"criterions": [
{
"exact_snippets": "distant metastasis",
"criterion": "distant metastasis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* History of invasive rectal malignancy, regardless of disease-free interval",
"criterions": [
{
"exact_snippets": "History of invasive rectal malignancy",
"criterion": "invasive rectal malignancy",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
},
{
"line": "* Fertile patients must use effective contraception",
"criterions": [
{
"exact_snippets": "Fertile patients",
"criterion": "fertility",
"requirements": [
{
"requirement_type": "status",
"expected_value": "fertile"
}
]
},
{
"exact_snippets": "must use effective contraception",
"criterion": "contraception use",
"requirements": [
{
"requirement_type": "necessity",
"expected_value": true
}
]
}
]
},
{
"line": "* Uncontrolled hypertension",
"criterions": [
{
"exact_snippets": "Uncontrolled hypertension",
"criterion": "hypertension",
"requirements": [
{
"requirement_type": "control",
"expected_value": "uncontrolled"
}
]
}
]
},
{
"line": "* Cardiovascular disease that would preclude study treatment or follow-up",
"criterions": [
{
"exact_snippets": "Cardiovascular disease that would preclude study treatment or follow-up",
"criterion": "cardiovascular disease",
"requirements": [
{
"requirement_type": "impact on study",
"expected_value": "preclude study treatment or follow-up"
}
]
}
]
},
{
"line": "* Lack of upper gastrointestinal tract integrity or malabsorption syndrome,active upper gastrointestinal tract bleeding",
"criterions": [
{
"exact_snippets": "Lack of upper gastrointestinal tract integrity",
"criterion": "upper gastrointestinal tract integrity",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "malabsorption syndrome",
"criterion": "malabsorption syndrome",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "active upper gastrointestinal tract bleeding",
"criterion": "upper gastrointestinal tract bleeding",
"requirements": [
{
"requirement_type": "activity",
"expected_value": true
}
]
}
]
},
{
"line": "* Synchronous colon cancer",
"criterions": [
{
"exact_snippets": "Synchronous colon cancer",
"criterion": "synchronous colon cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Pregnant or nursing, Fertile patients do not use effective contraception",
"criterions": [
{
"exact_snippets": "Pregnant",
"criterion": "pregnancy status",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "nursing",
"criterion": "nursing status",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "Fertile patients do not use effective contraception",
"criterion": "contraception use",
"requirements": [
{
"requirement_type": "usage",
"expected_value": true
}
]
}
]
},
{
"line": "* Other malignancy within the past 5 years except effectively treated squamous cell or basal cell skin cancer, melanoma in situ, carcinoma in situ of the cervix, or carcinoma in situ of the colon or rectum",
"criterions": [
{
"exact_snippets": "Other malignancy within the past 5 years",
"criterion": "other malignancy",
"requirements": [
{
"requirement_type": "time frame",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 5,
"unit": "years"
}
]
}
}
]
},
{
"exact_snippets": "except effectively treated squamous cell or basal cell skin cancer",
"criterion": "effectively treated squamous cell or basal cell skin cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "except ... melanoma in situ",
"criterion": "melanoma in situ",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "except ... carcinoma in situ of the cervix",
"criterion": "carcinoma in situ of the cervix",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "except ... carcinoma in situ of the colon or rectum",
"criterion": "carcinoma in situ of the colon or rectum",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* No psychiatric or addictive disorders, or other conditions that, in the opinion of the investigator, would preclude study participation",
"criterions": [
{
"exact_snippets": "No psychiatric or addictive disorders",
"criterion": "psychiatric disorders",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "No psychiatric or addictive disorders",
"criterion": "addictive disorders",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "other conditions that, in the opinion of the investigator, would preclude study participation",
"criterion": "other conditions precluding participation",
"requirements": [
{
"requirement_type": "investigator's opinion",
"expected_value": "would preclude study participation"
}
]
}
]
},
{
"line": "* patients refused to signed informed consent.",
"criterions": [
{
"exact_snippets": "patients refused to signed informed consent",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "signed",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [
{
"line": "* Diagnosis of adenocarcinoma of the rectum",
"criterions": [
{
"exact_snippets": "Diagnosis of adenocarcinoma of the rectum",
"criterion": "adenocarcinoma of the rectum",
"requirements": [
{
"requirement_type": "diagnosis",
"expected_value": true
}
]
}
]
},
{
"line": "* Age: 18-70 years old",
"criterions": [
{
"exact_snippets": "Age: 18-70 years old",
"criterion": "age",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 18,
"unit": "years"
},
{
"operator": "<=",
"value": 70,
"unit": "years"
}
]
}
}
]
}
]
},
{
"line": "* Signed informed consent; able to comply with study and/or follow- up procedures",
"criterions": [
{
"exact_snippets": "Signed informed consent",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "signed",
"expected_value": true
}
]
},
{
"exact_snippets": "able to comply with study and/or follow- up procedures",
"criterion": "compliance with study procedures",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
}
]
},
{
"line": "* Stage of the primary tumor may be determined by ultrasound or MRI",
"criterions": [
{
"exact_snippets": "Stage of the primary tumor",
"criterion": "stage of the primary tumor",
"requirements": [
{
"requirement_type": "determination method",
"expected_value": [
"ultrasound",
"MRI"
]
}
]
}
]
},
{
"line": "* Stage II (T3-4, N0 [N0 is defined as all imaged lymph nodes < 1.0 cm]) OR stage III (T1-4, N1-2 [with the definition of a clinically positive lymph node being any node ≥ 1.0 cm]",
"criterions": [
{
"exact_snippets": "Stage II (T3-4, N0 [N0 is defined as all imaged lymph nodes < 1.0 cm])",
"criterion": "cancer stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": "II"
},
{
"requirement_type": "tumor size",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "T"
}
},
{
"requirement_type": "lymph node involvement",
"expected_value": "N0"
},
{
"requirement_type": "lymph node size",
"expected_value": {
"operator": "<",
"value": 1.0,
"unit": "cm"
}
}
]
},
{
"exact_snippets": "stage III (T1-4, N1-2 [with the definition of a clinically positive lymph node being any node ≥ 1.0 cm]",
"criterion": "cancer stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": "III"
},
{
"requirement_type": "tumor size",
"expected_value": {
"operator": ">=",
"value": 1,
"unit": "T"
}
},
{
"requirement_type": "lymph node involvement",
"expected_value": [
"N1",
"N2"
]
},
{
"requirement_type": "lymph node size",
"expected_value": {
"operator": ">=",
"value": 1.0,
"unit": "cm"
}
}
]
}
]
},
{
"line": "* Tumor palpable by digital rectal exam OR accessible by proctoscope or sigmoidoscope",
"criterions": [
{
"exact_snippets": "Tumor palpable by digital rectal exam",
"criterion": "tumor palpability",
"requirements": [
{
"requirement_type": "method",
"expected_value": "digital rectal exam"
}
]
},
{
"exact_snippets": "Tumor ... accessible by proctoscope",
"criterion": "tumor accessibility",
"requirements": [
{
"requirement_type": "method",
"expected_value": "proctoscope"
}
]
},
{
"exact_snippets": "Tumor ... accessible by ... sigmoidoscope",
"criterion": "tumor accessibility",
"requirements": [
{
"requirement_type": "method",
"expected_value": "sigmoidoscope"
}
]
}
]
},
{
"line": "* Distal border of the tumor must be located < 12 cm from the anal verge",
"criterions": [
{
"exact_snippets": "Distal border of the tumor ... < 12 cm from the anal verge",
"criterion": "distal border of the tumor location",
"requirements": [
{
"requirement_type": "distance from anal verge",
"expected_value": {
"operator": "<",
"value": 12,
"unit": "cm"
}
}
]
}
]
},
{
"line": "* Tumor amenable to curative resection",
"criterions": [
{
"exact_snippets": "Tumor amenable to curative resection",
"criterion": "tumor",
"requirements": [
{
"requirement_type": "amenability to curative resection",
"expected_value": true
}
]
}
]
},
{
"line": "* Leukocytes ≥ 3.0 x109/ L, absolute neutrophil count (ANC) ≥ 1.5 x109/ L, platelet count ≥ 100 x109/ L, hemoglobin (Hb) ≥ 9g/ dL.",
"criterions": [
{
"exact_snippets": "Leukocytes ≥ 3.0 x109/ L",
"criterion": "leukocytes",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 3.0,
"unit": "x10^9/L"
}
}
]
},
{
"exact_snippets": "absolute neutrophil count (ANC) ≥ 1.5 x109/ L",
"criterion": "absolute neutrophil count (ANC)",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1.5,
"unit": "x10^9/L"
}
}
]
},
{
"exact_snippets": "platelet count ≥ 100 x109/ L",
"criterion": "platelet count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 100,
"unit": "x10^9/L"
}
}
]
},
{
"exact_snippets": "hemoglobin (Hb) ≥ 9g/ dL",
"criterion": "hemoglobin (Hb)",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 9,
"unit": "g/dL"
}
}
]
}
]
},
{
"line": "* Total bilirubin ≤1.5 x the upper limit of normal (ULN).",
"criterions": [
{
"exact_snippets": "Total bilirubin ≤1.5 x the upper limit of normal (ULN).",
"criterion": "total bilirubin",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 1.5,
"unit": "x ULN"
}
}
]
}
]
},
{
"line": "* Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤ 5 x ULN.",
"criterions": [
{
"exact_snippets": "Alanine aminotransferase (ALT) ... ≤ 5 x ULN.",
"criterion": "Alanine aminotransferase (ALT) level",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 5,
"unit": "x ULN"
}
}
]
},
{
"exact_snippets": "aspartate aminotransferase (AST) ≤ 5 x ULN.",
"criterion": "Aspartate aminotransferase (AST) level",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 5,
"unit": "x ULN"
}
}
]
}
]
},
{
"line": "* Alkaline phosphatase limit ≤ 5x ULN.",
"criterions": [
{
"exact_snippets": "Alkaline phosphatase limit ≤ 5x ULN.",
"criterion": "alkaline phosphatase",
"requirements": [
{
"requirement_type": "limit",
"expected_value": {
"operator": "<=",
"value": 5,
"unit": "x ULN"
}
}
]
}
]
},
{
"line": "* Amylase and lipase ≤ 1.5 x the ULN.",
"criterions": [
{
"exact_snippets": "Amylase ... ≤ 1.5 x the ULN.",
"criterion": "amylase level",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 1.5,
"unit": "x ULN"
}
}
]
},
{
"exact_snippets": "lipase ≤ 1.5 x the ULN.",
"criterion": "lipase level",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 1.5,
"unit": "x ULN"
}
}
]
}
]
},
{
"line": "* Serum creatinine ≤ 1.5 x the ULN.",
"criterions": [
{
"exact_snippets": "Serum creatinine ≤ 1.5 x the ULN.",
"criterion": "serum creatinine",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 1.5,
"unit": "x the ULN"
}
}
]
}
]
},
{
"line": "* Calculated creatinine clearance or 24 hour creatinine clearance ≥ 50 mL/ min.",
"criterions": [
{
"exact_snippets": "Calculated creatinine clearance ... ≥ 50 mL/ min.",
"criterion": "calculated creatinine clearance",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": ">=",
"value": 50,
"unit": "mL/min"
}
}
]
},
{
"exact_snippets": "24 hour creatinine clearance ≥ 50 mL/ min.",
"criterion": "24 hour creatinine clearance",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": ">=",
"value": 50,
"unit": "mL/min"
}
}
]
}
]
},
{
"line": "* No renal disease that would preclude study treatment or follow-up",
"criterions": [
{
"exact_snippets": "No renal disease that would preclude study treatment or follow-up",
"criterion": "renal disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* ECOG status: 0~1",
"criterions": [
{
"exact_snippets": "ECOG status: 0~1",
"criterion": "ECOG status",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 1,
"unit": "N/A"
}
]
}
}
]
}
]
}
],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": [
{
"line": "Inclusion Criteria",
"criterions": []
},
{
"line": "* Adequate bone marrow, hepatic and renal function as assessed by the following laboratory requirements conducted within 7 days of starting study treatment:",
"criterions": [
{
"exact_snippets": "Adequate bone marrow",
"criterion": "bone marrow function",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": "adequate"
}
]
},
{
"exact_snippets": "adequate ... hepatic",
"criterion": "hepatic function",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": "adequate"
}
]
},
{
"exact_snippets": "adequate ... renal function",
"criterion": "renal function",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": "adequate"
}
]
}
]
}
]
}